● DAMMNEWS STORY INTEL • ROUTE A LOCAL/FREE • NO PAID AI API ●
DAMMNEWS®
Independent aggregation • v2.4.13 • 2026-08-05

SOUTH KOREAN BIOTECH BETS ON DONATED HUMAN FAT PRODUCT TO FIX ‘OZEMPIC FACE’

1 min read • 1 hr ago • News - South China Morning Post • [src]
SOURCE SPECTRUM: South China Morning Post Unrated
LEFTCENTRERIGHTUNRATED
Third-party classification: Not ratedmethod and full source list. Bias is not a truth score.
REPORT A PROBLEM WITH THIS SOURCE
Reports are reviewed by the DAMMNEWS administrator. Please do not include personal or sensitive information.

WHAT HAPPENED

“Ozempic face” could spawn the next K-beauty craze. South Korean biotech L&C Bio plans to launch an injectable skin booster made from donated human fat to restore lost facial volume, betting demand for cosmetic fixes tied to blockbuster weight-loss drugs will drive its…

News - South China Morning Post reports that “Ozempic face” could spawn the next K-beauty craze.

The report adds: South Korean biotech L&C Bio plans to launch an injectable skin booster made from donated human fat to restore lost facial volume, betting demand for cosmetic fixes tied to blockbuster weight-loss drugs will drive its…

L&C – which pioneered the use of donated human tissue in K-beauty skin boosters – developed the technology about five years ago, CEO Lee Whan Chul said in an interview.

This report is covered across the current DAMMNEWS feeds. Technology stories often mix a product announcement with claims about availability, performance or impact. Those parts should be checked separately.

This is a developing report. DAMMNEWS will surface related coverage as closely matched reporting enters the live cache.

DAMMNEWS RSS BRIEFING — generated locally from the available News - South China Morning Post headline and RSS excerpt. It is not a summary of the full source article.

ADVERTISEMENT

RELATED DAMMNEWS COVERAGE

Built locally from the available RSS excerpts for this story and closely related DAMMNEWS coverage. Statements are attributed to their feed source; no paid AI API was used. Short excerpts can omit important context, so the original source remains essential.
READ FULL AT SOURCE →
ADVERTISEMENT
TEXT MODE PRINT SHARE: X Facebook Email ← Front page
ADVERTISEMENT
DAMMNEWS® 2026 • Local rules-based story intelligence • Original source remains one click away
RSSSource SpectrumAboutPrivacyContactTerms